Cargando…
Phosphatidylinositol 3-kinase pathway activation in breast cancer brain metastases
INTRODUCTION: Activation status of the phosphatidylinositol 3-kinase (PI3K) pathway in breast cancer brain metastases (BCBMs) is largely unknown. We examined expression of phospho(p)-AKT, p-S6, and phosphatase and tensin homologue (PTEN) in BCBMs and their implications for overall survival (OS) and...
Autores principales: | Adamo, Barbara, Deal, Allison M, Burrows, Emily, Geradts, Joseph, Hamilton, Erika, Blackwell, Kimberly L, Livasy, Chad, Fritchie, Karen, Prat, Aleix, Harrell, J Chuck, Ewend, Matthew G, Carey, Lisa A, Miller, C Ryan, Anders, Carey K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326567/ https://www.ncbi.nlm.nih.gov/pubmed/22132754 http://dx.doi.org/10.1186/bcr3071 |
Ejemplares similares
-
Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
por: Harrell, J. Chuck, et al.
Publicado: (2011) -
A compact VEGF signature associated with distant metastases and poor outcomes
por: Hu, Zhiyuan, et al.
Publicado: (2009) -
A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience
por: McKee, Megan J., et al.
Publicado: (2016) -
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
por: Prat, Aleix, et al.
Publicado: (2010) -
Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
por: Prat, Aleix, et al.
Publicado: (2013)